# International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis

> **NCT02762994** · PHASE2 · COMPLETED · sponsor: **Biocad** · enrollment: 120 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** BCD-085
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02762994
- **Lead sponsor:** Biocad
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2021-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02762994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02762994, "International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02762994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*